Quantification of viability in organotypic multicellular spheroids of human malignant glioma using lactate dehydrogenase activity: A rapid and reliable automated assay

被引:18
作者
Hamer, PCD
Jonker, A
Leenstra, S
Ruijter, JM
Van Noorden, CJF
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Neurosurg, NL-1100 DD Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1100 DD Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Anat & Embryol, NL-1100 DD Amsterdam, Netherlands
关键词
spheroids; glioma; lactate dehydrogenase; enzyme histochemistry; metabolic activity; toxicity test; biological assay; drug screening assays; image cytometry; cryostat sections;
D O I
10.1369/jhc.4A6301.2005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Organotypic spheroids from malignant glioma resemble the biological complexity of the original tumor and are therefore appealing to study anticancer drug responses. Accurate and reproducible quantification of response effect has been lacking to determine drug responses in this three-dimensional tumor model. Lactate dehydrogenase (LDH) activity was demonstrated in cryostat sections of spheroids using the tetrazolium salt method. Calibrated digital image acquisition of the stained cryostat sections enables quantification of LDH activity. Fully automated image cytometry reliably demarcates LDH-active and LDH-inactive tissue areas by thresholding at specific absorbance values. The viability index (VI) was calculated as ratio of LDH-active areas and total spheroid tissue areas. Duplicate staining and processing on the same tissue showed good correlation and therefore reproducibility. Sodium azide incubation of spheroids induced reduction in VI to almost zero. We conclude that quantification of viability in cryostat sections of organotypic multicellular spheroids from malignant glioma can be performed reliably and reproducibly with this approach.
引用
收藏
页码:23 / 34
页数:12
相关论文
共 64 条
[1]  
Allen Matthew, 1994, Clinical Materials, V16, P189
[2]   Non-cytotoxic therapies for malignant gliomas [J].
Basso, U ;
Ermani, M ;
Vastola, F ;
Brandes, AA .
JOURNAL OF NEURO-ONCOLOGY, 2002, 58 (01) :57-69
[3]   The development of necrosis and apoptosis in glioma: experimental findings using spheroid culture systems [J].
Bell, HS ;
Whittle, IR ;
Walker, M ;
Leaver, HA ;
Wharton, SB .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2001, 27 (04) :291-304
[4]   MULTICELLULAR TUMOR SPHEROIDS FROM HUMAN GLIOMAS MAINTAINED IN ORGAN-CULTURE [J].
BJERKVIG, R ;
TONNESEN, A ;
LAERUM, OD ;
BACKLUND, EO .
JOURNAL OF NEUROSURGERY, 1990, 72 (03) :463-475
[5]  
Bjerkvig Rolf, 1997, Current Opinion in Oncology, V9, P223, DOI 10.1097/00001622-199709030-00002
[6]   New strategy developments in brain tumor therapy [J].
Brandes, AA ;
Basso, U ;
Pasetto, LM ;
Ermani, M .
CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (16) :1553-1580
[7]   Human health effects of sodium azide exposure: A literature review and analysis [J].
Chang, SJ ;
Lamm, SH .
INTERNATIONAL JOURNAL OF TOXICOLOGY, 2003, 22 (03) :175-186
[8]   CYTOREDUCTIVE EFFECTS OF ANTITRANSFERRIN RECEPTORS IMMUNOTOXINS IN A MULTICELLULAR TUMOR SPHEROID MODEL [J].
CHIGNOLA, R ;
FORONI, R ;
CANDIANI, C ;
FRANCESCHI, A ;
PASTI, M ;
STEVANONI, G ;
ANSELMI, C ;
TRIDENTE, G ;
COLOMBATTI, M .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (02) :268-274
[9]   HETEROGENEOUS RESPONSE OF INDIVIDUAL MULTICELLULAR TUMOR SPHEROIDS TO IMMUNOTOXINS AND RICIN TOXIN [J].
CHIGNOLA, R ;
FORONI, R ;
FRANCESCHI, A ;
PASTI, M ;
CANDIANI, C ;
ANSELMI, C ;
FRACASSO, G ;
TRIDENTE, G ;
COLOMBATTI, M .
BRITISH JOURNAL OF CANCER, 1995, 72 (03) :607-614
[10]   Autologous spheroid culture: a screening tool for human brain tumour invasion [J].
de Ridder, L ;
Cornelissen, M ;
de Ridder, D .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2000, 36 (2-3) :107-122